ACI Worldwide Inc. (ACIW) Financials Nov 14, 2014, 4:56
ACI Worldwide Inc. (ACIW) Financials Nov 14, 2014, 4:56 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for ACI Worldwide Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 405.76M 418.42M 465.1M 666.58M 864.93M
Cost of Goods Sold (COGS) incl. D&A 145.64M 150.05M 156.34M 262.65M 400.2M
COGS excluding D&A 121.91M 123.7M 127.96M 211.87M 330.23M
Depreciation & Amortization Expense 23.73M 26.35M 28.38M 50.78M 69.97M
Depreciation 6.34M 6.65M 7.54M 13.28M 18.75M
Amortization of Intangibles 17.39M 19.7M 20.84M 37.5M 51.22M
Gross Income 260.12M 268.37M 308.75M 403.93M 464.73M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 215.35M 214.53M 235.82M 278.86M 298.29M
Research & Development 77.51M 74.08M 90.18M 133.76M 142.56M
Other SG&A 137.84M 140.45M 145.65M 145.1M 155.74M
Other Operating Expense 0 0 0 0 0
Unusual Expense 3.79M 353,000 6.7M 49.1M 43.39M
EBIT after Unusual Expense (3.79M) (353,000) (6.7M) (49.1M) (43.39M)
Non Operating Income/Expense (6.06M) (3.46M) (802,000) (1.2M) (3.33M)
Non-Operating Interest Income 1.04M 665,000 1.32M 914,000 659,000
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 2.86M 2M 2.43M 10.42M 27.22M
Gross Interest Expense 2.86M 2M 2.43M 10.42M 27.22M
Interest Capitalized 0 0 0 0 0
Pretax Income 33.11M 48.7M 64.31M 65.27M 93.16M
Income Tax 13.48M 21.51M 18.46M 16.42M 29.29M
Income Tax - Current Domestic 11.38M 3.5M 5.8M 2.39M 10M
Income Tax - Current Foreign 6.47M 6.37M 5.15M 9.26M 9.72M
Income Tax - Deferred Domestic (5.62M) 11.63M 7.08M (86,000) 7.8M
Income Tax - Deferred Foreign 1.25M 17,000 436,000 4.86M 1.77M
Income Tax Credits - 0 0 - 0
Equity in Affiliates - 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 19.63M 27.2M 45.85M 48.85M 63.87M
Minority Interest Expense 0 0 0 0 0
Net Income 19.63M 27.2M 45.85M 48.85M 63.87M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 19.63M 27.2M 45.85M 48.85M 63.87M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 19.63M 27.2M 45.85M 48.85M 63.87M
EPS (Basic) 0.19 0.27 0.46 0.42 0.54
Basic Shares Outstanding 103.1M 100.68M 100.37M 116.09M 117.88M
EPS (Diluted) 0.19 0.27 0.45 0.41 0.53
Diluted Shares Outstanding 103.66M 101.61M 102.58M 119.71M 120.05M
EBITDA 68.5M 80.2M 101.31M 175.85M 236.41M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...
Continue Reading
Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...
Continue Reading
Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...
Continue Reading
Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...
Continue Reading
Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...
Continue Reading
Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...
Continue Reading
New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...
Continue Reading
Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...
Continue Reading
Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...
Continue Reading
When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...
Continue Reading
Top 5 Most Recently Viewed Articles
The Expanding Landscape of the Automotive Key Blank Market The automotive key blank market is experiencing a transformative phase, poised to grow from USD 6.29 billion in 2025 to an impressive USD 9.67 billion by 2034. This remarkable growth reflects the industry’s ongoing adaptation to technological advancements, particularly the rising adoption of smart and automated...
Continue Reading
Insights into the Expanding Meat Processing Equipment Market The global meat processing equipment market is anticipated to experience significant growth, projected to reach USD 16.36 billion by 2032. This remarkable increase from its value of USD 11.25 billion in 2024 represents a robust compounded annual growth rate (CAGR) of 4.86% from 2025 to 2032. The factors driving...
Continue Reading
Fed's Waller Emphasizes Importance of Rate Cuts Christopher Waller, a Governor at the Federal Reserve, has spoken out about the economic challenges facing the labor market. He is advocating for a reduction in the Fed’s policy rate during the next meeting, scheduled for December. His approach centers on the need to address the risks associated with a weakening labor...
Continue Reading
Global Initiative on Ageing and Longevity Launches U.S. Chapter The Global Initiative on Ageing and Longevity (GIA-L) has propelled its mission forward by launching a North American Chapter. This initiative is designed to accelerate innovation and foster significant business growth while addressing the changing demographics and needs of an aging population. The GIA-L...
Continue Reading
Investigating Extreme Networks: What You Need to Know Faruqi & Faruqi, LLP, a well-known national securities law firm, is currently looking into possible claims on behalf of investors in Extreme Networks, Inc. (NASDAQ: EXTR). The firm is reaching out to investors who have incurred losses exceeding $100,000 to discuss their options and legal rights. With the situation...
Continue Reading